◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › BMRN

BioMarin Pharmaceutical Inc. (BMRN) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-15

BioMarin Pharmaceutical Inc. (BMRN) operates in the Biotechnology industry and is headquartered in San Rafael, United States with about 3,221 employees. Its market capitalization is roughly $11 billion. In the fiscal year ended 2025-12-31, BMRN reported $3.2B in revenue and $349M in net income.

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Interactive charts & full statements → Open the BMRN valuation workbench →

BMRN Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$3.2B$2.9B$2.4B$2.1B
Gross Profit$2.5B$2.3B$1.9B$1.6B
Operating Income (EBIT)$410M$474M$186M$57M
Net Income$349M$427M$168M$142M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BMRN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$766M$875M$776M$825M$745M
Gross Profit$571M$599M$636M$675M$594M
Operating Income (EBIT)$130M($45M)($47M)$277M$224M
Net Income$106M($47M)($31M)$240M$186M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BMRN Free Cash Flow History

BMRN Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$7.6B$7.0B$6.8B$6.4B
Total Liabilities$1.5B$1.3B$1.9B$1.8B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BMRN viewer.

Other Companies in Biotechnology

← BMRCAll stocksBMY →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.